Journal Article DZNE-2020-03284

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Potenziell inadäquate Medikamente bei älteren hausärztlich versorgten Patientinnen und Patienten : Eine retrospektive Längsschnittanalyse | Potentially inappropriate medication in elderly primary care patients : A retrospective, longitudinal analysis

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2013
Springer Heidelberg

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 56(7), 941-949 () [10.1007/s00103-013-1767-5]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Elderly people are often burdened by several diseases. This accounts for a higher medication intake and increases the risk of adverse drug events. To minimize this risk, several lists (Beers, PRISCUS) have been published of drugs that elderly patients should not take. We present a longitudinal analysis of the use of potentially inappropriate medication (PIM) over a period 4.5 years in a cohort of patients aged 75 years or more.Data were collected from the prospective, multicenter, observational study 'German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe),' initially enrolling 3,327 patients. We investigated the prevalence of PIM by checking medications during visits to patients' homes. Furthermore, we analyzed the use of individual PIM agents over time.At baseline, we found a PIM prevalence of 29 % according to the PRISCUS list, which decreased to 25.0 % 4.5 years later (χ(2): 7.87, p = 0.004). The Beers list yielded a prevalence of 21 % at baseline, decreasing after 4.5 years to 17.1 % (χ(2): 10.77, p = 0.000). A time-dependent multilevel model confirmed these results. Older age, depression, and the use of numerous prescribed agents are independent risk factors for using a PRISCUS-PIM.Our results seem to support a trend toward a more rational drug therapy because fewer patients were prescribed PIM. Thus, for the individual patient, the risk of adverse effects and side effects is reduced as are the costs of these effects.

Keyword(s): Age Distribution (MeSH) ; Aged (MeSH) ; Aged, 80 and over (MeSH) ; Depression: drug therapy (MeSH) ; Depression: epidemiology (MeSH) ; Female (MeSH) ; Germany: epidemiology (MeSH) ; Health Services for the Aged: statistics & numerical data (MeSH) ; Health Services for the Aged: trends (MeSH) ; Humans (MeSH) ; Inappropriate Prescribing: statistics & numerical data (MeSH) ; Inappropriate Prescribing: trends (MeSH) ; Longitudinal Studies (MeSH) ; Male (MeSH) ; Polypharmacy (MeSH) ; Primary Health Care: statistics & numerical data (MeSH) ; Primary Health Care: trends (MeSH) ; Retrospective Studies (MeSH) ; Risk Factors (MeSH) ; Sex Distribution (MeSH)

Classification:

Contributing Institute(s):
  1. Pharmacoepidemiology (AG Hänisch)
  2. U Clinical Researchers - Bonn (U Clinical Researchers - Bonn)
  3. Clinical Alzheimer’s Disease Research (AG Jessen)
Research Program(s):
  1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)
  2. 345 - Population Studies and Genetics (POF3-345) (POF3-345)

Appears in the scientific report 2013
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; IF < 5 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-U Clinical Researchers \- Bonn
Document types > Articles > Journal Article
Institute Collections > BN DZNE > BN DZNE-AG Hänisch
Institute Collections > BN DZNE > BN DZNE-AG Jessen
Public records
Publications Database

 Record created 2020-02-18, last modified 2025-03-21


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)